Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1125816 Wheaton, IL
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$9,246,285
-$19,599 QoQ
Shares Held
113,354
-16.7% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#79
of 383 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. PTCT ranks #43 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 547,132 $341,158,687
2 INCY
Incyte Corp
 1,587,996 $180,015,226
3 CORT
Corcept Therapeutics Inc
 1,829,545 $159,078,937
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,179 $143,643,884
5 EXEL
Exelixis, Inc.
 2,543,353 $138,383,836
6 ALNY
Alnylam Pharmaceuticals, Inc.
 421,534 $126,894,380
7 KRYS
Krystal Biotech, Inc.
 324,900 $120,755,583
8 AXSM
Axsome Therapeutics, Inc.
 482,061 $117,994,070

All Filings in PTCT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,246,285 113,354
2026-03-31 $9,265,884 136,003
2025-12-31 $11,819,072 155,596
2025-09-30 $7,478,241 121,855
2025-06-30 $6,120,726 125,322
2025-03-31 $7,223,478 141,748
2024-12-31 $6,038,061 133,763
2024-09-30 $4,002,422 107,882
2024-06-30 $2,403,557 78,599
2024-03-31 $41,758,113 1,435,480
2023-09-30 $684,378 30,539
2023-06-30 $2,107,438 51,818
2023-03-31 $1,571,490 32,442
2022-12-31 $2,876,605 75,363
2022-09-30 $4,811,117 95,839
2022-06-30 $2,339,584 58,402
2022-03-31 $1,338,645 35,879
2021-12-31 $537,744 13,501
2021-03-31 $2,639,289 55,740
2020-09-30 $2,308,935 49,389
2020-06-30 $2,949,617 58,132
2020-03-31 $2,057,457 46,121